Travelers Companies, Inc. (TRV): what the price requires

At today's price, Travelers Companies, Inc. (TRV) is priced for 14.2% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/TRV

Headline

FieldValue
TickerTRV
CompanyTravelers Companies, Inc.
Sector / IndustryFinancial Services / Insurance
Current price$341.68/sh
CompositionBusiness Insurance 53% / Bond & Specialty Insurance 9% / Personal Insurance 37%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed14.2%
Return on equity now19.1%
ROE gap-4.9pp
Price-to-book2.27x

Solve inputs: computed at a 8.5% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~2.3pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.47σ
cohort percentile (of 80 peers)65
sustained it ~10 years at this level63%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.91x3justifies
Earnings0.63x2justifies
Relative0.85x3justifies
Growth1.15x1expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.0%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$558.110.61xyesTBVPS $126.35 × 4.42x (ROE (TTM) 23.8% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$398.860.86xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.7x (bear / base = reference held flat / bull), EV/EBITDA 22x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$376.400.91xyesBV/sh $146.46, ROE (TTM) 23.8%, ke 9.3%
Two-Stage Excess ReturnAsset$603.620.57xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$296.701.15xyesRev $48.9B, growth 4% (input: historical growth; tapered), Terminal P/S: 1.3x / 1.5x / 1.8x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$402.120.85xyesEPS $33.51, growth 2% (input: historical EPS growth), PEG=6.36 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$332.301.03xyes√(22.5 × EPS $33.51 × BVPS $146.46) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$1081.260.32xyesEPS $33.51 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$1256.630.27xyesEPS $33.51 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$362.270.94xyesEPS $33.51 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-2.7%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Start with the part of Travelers that has nothing to do with weather. The company sits on an investment portfolio that averaged $104.2 billion in 2025, and the income from it has been climbing as older bonds roll off and get reinvested at today's rates: pre-tax net investment income rose from $2.92 billion in 2023 to $3.59 billion in 2024 to $3.96 billion in 2025, with the average pre-tax yield moving from 3.2 percent to 3.8 percent over the same stretch, per the FY2025 10-K. The filing states plainly that "Net investment income is a material contributor to the Company's results of operations" (accession 0000086312-26-000065), and this contributor compounds quietly regardless of what the underwriting cycle does. Float, the premium dollars held between collection and claim payment, is earning more per dollar than it has in years, and the portfolio keeps growing as premiums grow.

The underwriting side is earning its keep too. The Q1 FY2026 combined ratio came in at 88.6 percent, meaning Travelers kept about 11 cents of underwriting profit on every premium dollar before investment income, with the underlying figure (stripping catastrophes and reserve changes) at 85.3 percent. That profitability spans all three segments rather than leaning on one: the 10-K shows FY2025 gross written premiums of $22.7 billion in Business Insurance, $4.3 billion in Bond & Specialty, and $17.4 billion in Personal Insurance, with total gross premiums up 3 percent over 2024. The bond and specialty book deserves a word: it is a surety and management-liability franchise that is 86.7 percent domestic with its largest state at under 10 percent of premiums, per the 10-K's geographic breakdown, which is a diversified, fee-like corner of insurance that most personal-lines rivals do not have.

Then there is what management does with the profits. Over the trailing twelve months Travelers returned $5.53 billion to shareholders, $976 million in dividends and $4.55 billion in buybacks, the latter equal to roughly 60 percent of net income, and the share count is falling. The company's stated framework, from its Q3 2025 10-Q, is that "generally over time, the combination of dividends to common shareholders and common share repurchases will likely not exceed net income" (accession 0000086312-25-000069), with a carve-out to retain more capital when premium growth demands it. At 9.7 times trailing earnings against a sector median near 11, each repurchased share retires more earnings power than the average financial-sector buyback does. A company buying back its own stock this aggressively at a single-digit multiple, while returns on equity run near 19 percent, is telling you what it thinks the business is worth.

Bear Case

The structural truth a holder has to sit with is this: Travelers underwrites weather, and the earnings the market is capitalizing arrived in quarters when the weather cooperated. The FY2025 10-K is candid about the exposure: "The Company has geographic exposure to catastrophe losses, which include hurricanes, tornadoes and other windstorms, earthquakes, hail, wildfires, severe winter weather, floods, tsunamis, volcanic eruptions, solar flares and other naturally-occurring events" (accession 0000086312-26-000065). Q1 FY2026 showed both sides of that coin in a single comparison: catastrophe losses of $761 million produced $7.78 of quarterly EPS, while the year-ago quarter's $2.27 billion of catastrophe losses left just $1.70. The earning power did not change between those two quarters. The weather did. The same 10-K warns that high catastrophe losses, driven partly by "increased concentrations of insured exposures in catastrophe-prone areas and changing climate conditions", could materially affect results, ratings, and the cost of reinsurance. That is not boilerplate for a company whose largest segment after commercial lines is personal home and auto insurance.

The cycle is the second problem, and it is already visible in the numbers analysts are writing down. Consensus for Q2 FY2026 sits at $4.87 of diluted EPS, down about 25 percent from $6.51 a year earlier, and the debate under that number is whether commercial pricing has rolled over while personal-lines competition re-intensifies. The peer filings say the fight is real: Progressive's 10-K reports its personal auto business experienced decreases in retention during 2025 amid increased shopping, and Cincinnati Financial's 10-K discloses personal lines new business written premiums fell $128 million, or 21 percent, in 2025 as competitors reposition on rate. When the two most disciplined personal-lines competitors are respectively losing retention and walking away from business, the industry is telling you the easy rate gains are behind it. Long-tail reserves add a slower-moving risk: the 10-K notes that "The emergence of a greater number of asbestos claims beyond that which is anticipated may result in adverse loss reserve development", a reminder that decades-old policies still reach into current earnings.

Now connect that to the price. At roughly 2.3 times book, today's price needs Travelers to sustain a return on equity of about 14.3 percent for years; it has recently been earning about 19.1 percent, so there is cushion, but only about 62 percent of firms earning returns at this level have sustained them for a decade. The bear case is not that Travelers fails. It is that underwriting margins mean-revert as pricing softens and catastrophe loads normalize, returns drift down toward the pack, and the price-to-book multiple the market pays compresses along with them. The 10-K itself names one mechanism: "our competitive position could be impacted if we are unable to deploy, in a cost effective and competitive manner, technology such as artificial intelligence and machine learning", because underwriting edge is increasingly a data-and-models contest where scale advantages can erode quickly. Paying an upper-half peer multiple for returns at a cyclical high is a bet that this cycle fades slowly. Cycles are not known for their courtesy.

Valuation

An insurer is priced off the return it earns on its capital, so the place to start is price against book value. At $338.86 (July 2026), the market is paying roughly 2.3 times book value per share of $146.46, and that price embeds an assumption: Travelers sustains a return on equity of about 14.3 percent going forward. Against what the company has recently been earning, about 19.1 percent, the assumption is within reach of its own record rather than a stretch beyond it. The demanding parts are relative: the multiple sits in the upper half of its peer group's price-to-book, and among companies that have earned returns at this level, only about 62 percent sustained them for a decade. The bet is not that Travelers becomes something better than it is. It is that the current version persists.

The valuation methods, read as a group, mostly support the price. The asset-value, earnings-power, and peer-multiple families each land above where the stock trades, and only the forward-growth methods read it as slightly rich. That pattern describes a value-supported name rather than a growth bet: at 9.7 times trailing earnings against a sector median of 11, the market is charging less per dollar of current profit than it does for the typical financial, and the premium shows up only in the price-to-book lens, where the strong recent returns have inflated the denominator's earning power. The inputs under those methods are filed, not modeled: the FY2025 10-K reports gross written premiums of $44.4 billion, up 3 percent over 2024 (accession 0000086312-26-000065), and pre-tax net investment income of $3.96 billion on average investments of $104.2 billion at a 3.8 percent average pre-tax yield, a yield that has risen for two consecutive years as the bond portfolio reprices.

The balance-sheet frame for an insurer is capital and payout rather than net debt, and on that frame the company returned about 63 percent of latest-fiscal-year earnings as dividends plus buybacks, $5.53 billion over the trailing twelve months, while the share count declined. Book value compounds under the buyback; the multiple takes care of itself only if the returns hold. What has to be true at today's price is a 14 percent-plus return on equity sustained through a softening pricing cycle and an ordinary run of catastrophe seasons, and the company currently earns comfortably above that bar. The distance between 19 percent earned and 14 percent required is the margin the price leaves for the cycle to take back.

Catalysts

The near-term calendar centers on July 17, 2026, when Travelers reports second-quarter results before the market opens with a call at 9 a.m. ET. Consensus sits at $4.87 of diluted EPS, down about 25 percent from $6.51 in the year-ago quarter, reflecting expectations of a heavier seasonal catastrophe load and softer margins rather than any single company-specific problem. The recent record leans the other way: Travelers has beaten consensus EPS in each of its last four reports, most recently in April when Q1 core income of $1.7 billion, or $7.71 per diluted share, cleared the $6.80 estimate on a core return on equity of 19.7 percent, helped by catastrophe losses of $761 million versus $2.27 billion a year earlier and after-tax net investment income up 9 percent to $833 million.

Analyst posture is split in a way that maps cleanly onto the cycle debate. Piper Sandler raised its price target from $329 to $340 with an Overweight rating after the Q1 print, citing the sub-90 combined ratio and underwriting income across all segments; the broader street counts 14 buy or outperform ratings against 16 holds and 3 underperforms. The bulls are underwriting margin durability; the holds are waiting to see whether commercial renewal pricing keeps pace with loss-cost inflation into the second half.

Through the August-to-October hurricane season, the items that move the story are the quarterly catastrophe load, the underlying combined ratio against Q1's 85.3 percent, renewal rate change in Business Insurance, and the trajectory of net investment income as maturing bonds reinvest at higher yields. Capital return runs alongside: buybacks were $1.985 billion in Q1, and the pace of repurchases in the back half will signal how management weighs its own stock against premium growth.

Peer Cohorts (Per Segment, With Filing Citations)

Business Insurance (reported)

Bond & Specialty Insurance (reported)

Personal Insurance (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 FY2026 earnings release · Barchart earnings preview via Yahoo Finance · company announcement via StockTitan · Barchart · Q1 FY2026 earnings release; Investing.com · Investing.com · TIKR

View the full interactive TRV report on boothcheck